ALK-Abelló
Notification of ownership in ALK
DGAP-News: ALK-Abelló 25.11.2014 / 18:30 --------------------------------------------------------------------- Copenhagen, 2014-11-25 18:30 CET (GLOBE NEWSWIRE) -- Pursuant to section 29 of the Danish Securities Trading Act, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) has received notification from Invesco Limited, that Invesco Canada Ltd. has increased its ownership in ALK-Abelló A/S. Invesco Canada Ltd. now owns 7.81% of the company share capital equivalent to 719,047 B shares. ALK-Abelló A/S For further information please contact: Jens Bager, President and CEO, tel. +45 4574 7576 Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525 Press: Martin Barlebo, tel. +45 4574 7901, mobile +45 2064 1143 About ALK ALK is a research-driven global pharmaceutical company focusing on allergy prevention, diagnosis and treatment. ALK is the world leader in allergy immunotherapy - a unique treatment of the underlying cause of allergy. The company has approximately 1,800 employees with subsidiaries, production facilities and distributors worldwide. ALK has entered into partnership agreements with Merck and Torii to commercialise sublingual allergy immunotherapy tablets in North America and Japan, respectively. The company is headquartered in Hørsholm, Denmark, and listed on NASDAQ Copenhagen. Find more information at www.alk.net. News Source: NASDAQ OMX --------------------------------------------------------------------- 25.11.2014 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: ALK-Abelló Denmark ISIN: DK0060027142 End of News DGAP News-Service --------------------------------------------------------------------- 299525 25.11.2014
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden